vs
FULLER H B CO（FUL）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是FULLER H B CO的1.6倍（$1.4B vs $892.0M），瑞思迈净利率更高（27.6% vs 7.5%，领先20.1%），瑞思迈同比增速更快（11.0% vs -2.8%），过去两年瑞思迈的营收复合增速更高（7.8% vs 5.0%）
H.B.富勒公司是总部位于美国明尼苏达州圣保罗的跨国粘合剂制造企业，全球第四大粘合剂及密封剂生产商。公司拥有超过20000种产品，广泛应用于建筑、工程、电子、卫生用品、食品包装等领域，在26个国家设有81座生产基地，2024年员工规模约7500人。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
FUL vs RMD — 直观对比
营收规模更大
RMD
是对方的1.6倍
$892.0M
营收增速更快
RMD
高出13.8%
-2.8%
净利率更高
RMD
高出20.1%
7.5%
两年增速更快
RMD
近两年复合增速
5.0%
损益表 — Q3 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $892.0M | $1.4B |
| 净利润 | $67.2M | $392.6M |
| 毛利率 | 32.0% | 61.8% |
| 营业利润率 | 12.3% | 34.6% |
| 净利率 | 7.5% | 27.6% |
| 营收同比 | -2.8% | 11.0% |
| 净利润同比 | 21.3% | 13.9% |
| 每股收益（稀释后） | $1.22 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FULRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $892.0M | $1.3B | ||
| Q2 25 | $898.1M | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $917.9M | $1.2B |
净利润FULRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | — | $392.6M | ||
| Q3 25 | $67.2M | $348.5M | ||
| Q2 25 | $41.8M | $379.7M | ||
| Q1 25 | — | $365.0M | ||
| Q4 24 | — | $344.6M | ||
| Q3 24 | $55.4M | $311.4M |
毛利率FULRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | 32.0% | 61.5% | ||
| Q2 25 | 31.9% | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | 30.0% | 58.6% |
营业利润率FULRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | — | 34.6% | ||
| Q3 25 | 12.3% | 33.4% | ||
| Q2 25 | 11.1% | 33.7% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | 11.4% | 31.6% |
净利率FULRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | — | 27.6% | ||
| Q3 25 | 7.5% | 26.1% | ||
| Q2 25 | 4.7% | 28.2% | ||
| Q1 25 | — | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | 6.0% | 25.4% |
每股收益（稀释后）FULRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | — | $2.68 | ||
| Q3 25 | $1.22 | $2.37 | ||
| Q2 25 | $0.76 | $2.58 | ||
| Q1 25 | — | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | $0.98 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $122.5M | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | $2.0B | $6.3B |
| 总资产 | $5.2B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资FULRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $122.5M | $1.4B | ||
| Q2 25 | $96.8M | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | $131.4M | $426.4M |
总债务FULRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益FULRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | $2.0B | $6.1B | ||
| Q2 25 | $1.9B | $6.0B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | $1.8B | $5.2B |
总资产FULRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | — | $8.5B | ||
| Q3 25 | $5.2B | $8.3B | ||
| Q2 25 | $5.1B | $8.2B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | $5.0B | $7.2B |
负债/权益比FULRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $99.0M | — |
| 自由现金流经营现金流 - 资本支出 | $68.9M | — |
| 自由现金流率自由现金流/营收 | 7.7% | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | 1.47× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FULRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $339.7M | ||
| Q3 25 | $99.0M | $457.3M | ||
| Q2 25 | — | $538.8M | ||
| Q1 25 | — | $578.7M | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | $169.4M | $325.5M |
自由现金流FULRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | $68.9M | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | $99.9M | $307.7M |
自由现金流率FULRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | 7.7% | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | 10.9% | 25.1% |
资本支出强度FULRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | 3.4% | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 7.6% | 1.5% |
现金转化率FULRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | 1.47× | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 3.06× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUL
| Hygiene Health And Consumable Adhesives | $386.1M | 43% |
| Engineering Adhesives | $272.3M | 31% |
| Building Adhesives Solutions | $233.7M | 26% |
RMD
暂无分部数据
